These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Herpes zoster vaccine effectiveness against herpes zoster and postherpetic neuralgia in New Zealand: a retrospective cohort study. Mbinta JF; Wang AX; Nguyen BP; Paynter J; Awuni PMA; Pine R; Sporle AA; Simpson CR Lancet Reg Health West Pac; 2023 Feb; 31():100601. PubMed ID: 36879782 [TBL] [Abstract][Full Text] [Related]
5. Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review. McKay SL; Guo A; Pergam SA; Dooling K Clin Infect Dis; 2020 Oct; 71(7):e125-e134. PubMed ID: 31677266 [TBL] [Abstract][Full Text] [Related]
6. Systematic review of incidence and complications of herpes zoster: towards a global perspective. Kawai K; Gebremeskel BG; Acosta CJ BMJ Open; 2014 Jun; 4(6):e004833. PubMed ID: 24916088 [TBL] [Abstract][Full Text] [Related]
7. Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012. Yanni EA; Ferreira G; Guennec M; El Hahi Y; El Ghachi A; Haguinet F; Espie E; Bianco V BMJ Open; 2018 Jun; 8(6):e020528. PubMed ID: 29880565 [TBL] [Abstract][Full Text] [Related]
8. Pediatric herpes zoster ophthalmicus: a systematic review. Hakim FE; Riaz K; Farooq A Graefes Arch Clin Exp Ophthalmol; 2023 Aug; 261(8):2169-2179. PubMed ID: 36949170 [TBL] [Abstract][Full Text] [Related]
9. A retrospective cohort study evaluating the incidence of herpes zoster and postherpetic neuralgia after a live attenuated Oka-strain herpes zoster vaccine in a real-world setting in Japan. Yaegashi M; Matsui H; Yoshida A; Ban H; Miyazaki R; Oda N; Hattori K; Motomura Y; Usami H; Matsushita H Vaccine; 2024 Jan; 42(3):464-470. PubMed ID: 38172019 [TBL] [Abstract][Full Text] [Related]
10. Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination. Johnson RW Aging Clin Exp Res; 2009 Jun; 21(3):236-43. PubMed ID: 19571648 [TBL] [Abstract][Full Text] [Related]
11. Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States. Thompson RR; Kong CL; Porco TC; Kim E; Ebert CD; Acharya NR Clin Infect Dis; 2021 Nov; 73(9):e3210-e3217. PubMed ID: 32829399 [TBL] [Abstract][Full Text] [Related]
12. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study. Borkar DS; Tham VM; Esterberg E; Ray KJ; Vinoya AC; Parker JV; Uchida A; Acharya NR Ophthalmology; 2013 Mar; 120(3):451-456. PubMed ID: 23207173 [TBL] [Abstract][Full Text] [Related]
13. Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention. Litt J; Cunningham AL; Arnalich-Montiel F; Parikh R Infect Dis Ther; 2024 Jul; 13(7):1439-1459. PubMed ID: 38834857 [TBL] [Abstract][Full Text] [Related]
14. Herpes zoster and postherpetic neuralgia in Catalonia (Spain). Salleras L; Salleras M; Salvador P; Soldevila N; Prat A; Garrido P; Domínguez A Hum Vaccin Immunother; 2015; 11(1):178-84. PubMed ID: 25483532 [TBL] [Abstract][Full Text] [Related]
15. Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination Uptake in a US Administrative Claims Database. Marcum ZA; Jain P; Embry A; Arakaki B; Estevez I; Viscidi E Open Forum Infect Dis; 2024 May; 11(5):ofae211. PubMed ID: 38737423 [TBL] [Abstract][Full Text] [Related]
16. Genital Herpes Zoster as Possible Indicator of HIV Infection. Ljubojević Hadžavdić S; Kovačević M; Skerlev M; Zekan Š Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486 [TBL] [Abstract][Full Text] [Related]
17. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Yawn BP; Saddier P; Wollan PC; St Sauver JL; Kurland MJ; Sy LS Mayo Clin Proc; 2007 Nov; 82(11):1341-9. PubMed ID: 17976353 [TBL] [Abstract][Full Text] [Related]
18. Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK. Marijam A; Vroom N; Bhavsar A; Posiuniene I; Lecrenier N; Vroling H Infect Dis Ther; 2024 May; 13(5):1083-1104. PubMed ID: 38656653 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Pellissier JM; Brisson M; Levin MJ Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938 [TBL] [Abstract][Full Text] [Related]
20. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study. Schmidt-Ott R; Schutter U; Simon J; Nautrup BP; von Krempelhuber A; Gopala K; Anastassopoulou A; Guignard A; Curran D; Matthews S; Espié E J Infect; 2018 May; 76(5):475-482. PubMed ID: 29428228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]